Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

3.310

-0.135 (-3.92%)

Jul 14, 2025, 4:00 PM - Market closed

Grace Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 14, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	46	31	32	21	54	120	Upgrade
Market Cap Growth	-2.84%	-2.84%	56.90%	-62.03%	-55.00%	250.73%	Upgrade
Enterprise Value	24	20	7	-10	8	92	Upgrade
Last Close Price	3.31	2.28	3.42	2.76	7.32	28.80	Upgrade
Debt / Equity Ratio	-	-	-	0.01	0.00	0.00	Upgrade
Asset Turnover	-	-	-	-	-	0.01	Upgrade
Quick Ratio	11.53	11.53	14.09	8.41	13.56	38.80	Upgrade
Current Ratio	11.77	11.77	14.26	8.59	13.89	39.50	Upgrade
Return on Equity (ROE)	-14.91%	-14.91%	-19.82%	-48.15%	-11.98%	-57.33%	Upgrade
Return on Assets (ROA)	-14.35%	-14.35%	-9.25%	-10.96%	-7.94%	-15.70%	Upgrade
Return on Capital (ROIC)	-16.24%	-16.24%	-10.83%	-12.86%	-9.23%	-19.45%	Upgrade
Buyback Yield / Dilution	-26.85%	-26.85%	-28.16%	-21.09%	-148.46%	-40.25%	Upgrade

Updated Jun 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q